Skip to content

Albany Molecular to go private at $21.75/share

June 6, 2017

Albany Molecular Research Inc. AMRI, +8.95% said Tuesday it has agreed to be acquired by private-equity firms The Carlyle Group and GTCR LLC for $21.75 a share in cash, equal to a 42% premium over its 60-day weighted average closing stock price. The deal has been approved by AMRI’s board and must now be approved by shareholders. The deal will be financed with a mixture of debt and equity financing, the sponsors said. AMRI shares were halted in premarket trade for the news, but have gained 5% in 2017, while the S&P 500 SPX, -0.12% has gained 9%.

http://on.mktw.net/2rwJPPP

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: